170 related articles for article (PubMed ID: 35734321)
21. Recurrence and treatment of adult primary nonmetastatic bladder rhabdomyosarcoma: A systematic review.
Nguyen A; Fassas S; Freidberg N; Sullo E; Whalen M
Urol Oncol; 2021 Nov; 39(11):774-780. PubMed ID: 34332845
[TBL] [Abstract][Full Text] [Related]
22. Defining the impact of prognostic factors at the time of relapse for nonmetastatic rhabdomyosarcoma.
Affinita MC; Ferrari A; Chiaravalli S; Melchionda F; Quaglietta L; Casanova M; Zanetti I; Scarzello G; Di Pasquale L; Di Cataldo A; Bisogno G
Pediatr Blood Cancer; 2020 Dec; 67(12):e28674. PubMed ID: 32860661
[TBL] [Abstract][Full Text] [Related]
23. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997).
Neville HL; Andrassy RJ; Lobe TE; Bagwell CE; Anderson JR; Womer RB; Crist WM; Wiener ES
J Pediatr Surg; 2000 Feb; 35(2):317-21. PubMed ID: 10693687
[TBL] [Abstract][Full Text] [Related]
24. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.
Gerber NK; Wexler LH; Singer S; Alektiar KM; Keohan ML; Shi W; Zhang Z; Wolden S
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):58-63. PubMed ID: 23414767
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological characteristics and therapeutic effects of adult rhabdomyosarcoma patients].
Yang QK; Li SL; Chen T; Yao ZX; Zhang XJ
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):873-877. PubMed ID: 31770858
[No Abstract] [Full Text] [Related]
26. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.
Breneman JC; Lyden E; Pappo AS; Link MP; Anderson JR; Parham DM; Qualman SJ; Wharam MD; Donaldson SS; Maurer HM; Meyer WH; Baker KS; Paidas CN; Crist WM
J Clin Oncol; 2003 Jan; 21(1):78-84. PubMed ID: 12506174
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study.
Lee JS; Lim SM; Rha SY; Roh JK; Cho YJ; Shin KH; Yang WI; Kim SH; Kim HS
J Clin Pathol; 2014 Jan; 67(1):33-9. PubMed ID: 23922356
[TBL] [Abstract][Full Text] [Related]
28. Head and neck rhabdomyosarcoma in adults.
Wu Y; Li C; Zhong Y; Guo W; Ren G
J Craniofac Surg; 2014 May; 25(3):922-5. PubMed ID: 24777012
[TBL] [Abstract][Full Text] [Related]
29. Rhabdomyosarcoma in children: a SEER population based study.
Perez EA; Kassira N; Cheung MC; Koniaris LG; Neville HL; Sola JE
J Surg Res; 2011 Oct; 170(2):e243-51. PubMed ID: 21529833
[TBL] [Abstract][Full Text] [Related]
30. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
Ferrari A; Dileo P; Casanova M; Bertulli R; Meazza C; Gandola L; Navarria P; Collini P; Gronchi A; Olmi P; Fossati-Bellani F; Casali PG
Cancer; 2003 Aug; 98(3):571-80. PubMed ID: 12879475
[TBL] [Abstract][Full Text] [Related]
31. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
[TBL] [Abstract][Full Text] [Related]
32. Durability of oncological outcomes of combination chemotherapy as a monotherapy for a select patient subset with non-metastatic non-alveolar bladder/prostate rhabdomyosarcoma.
Abdelhalim A; Atwa AM; Helmy TE; Dawaba ME; Elashry R; Hafez AT
J Pediatr Urol; 2021 Aug; 17(4):535.e1-535.e8. PubMed ID: 34092511
[TBL] [Abstract][Full Text] [Related]
33. Rhabdomyosarcoma of the female genitourinary tract: Primary and relapsed disease in infants and older children. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Matle M; Vokuhl C; Hallmen E; von Kalle T; Münter M; Timmermann B; Bielack SS; Klingebiel T; Koscielniak E; Seitz G;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28889. PubMed ID: 33438323
[TBL] [Abstract][Full Text] [Related]
34. Surgical treatment of pediatric rhabdomyosarcoma in the parameningeal-nonparameningeal region.
Liu Z; Zhu F; Cao W; Sun J; Zhang C; He Y
J Craniomaxillofac Surg; 2020 Jan; 48(1):75-82. PubMed ID: 31902716
[TBL] [Abstract][Full Text] [Related]
35. DNA ploidy as a prognostic factor in rhabdomyosarcoma. Analysis of 35 cases with image cytometry.
Pohar-Marinsek Z; Bracko M; Lavrencak J; Us-Krasovec M
Anal Quant Cytol Histol; 2003 Aug; 25(4):235-42. PubMed ID: 12961831
[TBL] [Abstract][Full Text] [Related]
36. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma?
Fetzko S; Fonseca A; Frances Wedekind M; Gupta AA; Setty BA; Schraw J; Lupo PJ; Guillerman RP; Butala AA; Russell H; Nicholls L; Walterhouse D; Hawkins DS; Okcu MF
J Pediatr Hematol Oncol; 2022 Aug; 44(6):305-312. PubMed ID: 35137727
[TBL] [Abstract][Full Text] [Related]
37. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma.
Sun C; Liu C; Li S; Li H; Wang Y; Xie Y; Li B; Cui X; Chen Y; Zhang W; Li F
Int J Clin Exp Pathol; 2014; 7(4):1606-15. PubMed ID: 24817957
[TBL] [Abstract][Full Text] [Related]
39. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.
Hayes-Jordan A; Stoner JA; Anderson JR; Rodeberg D; Weiner G; Meyer WH; Hawkins DS; Arndt CA; Paidas C;
J Pediatr Surg; 2008 May; 43(5):831-6. PubMed ID: 18485948
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome of rhabdomyosarcoma in adolescent and adult patients: single center experience from Turkey.
Ustuner Z; Basaran M; Dizdar Y; Agaoglu FY; Bilgic B; Sakar B; Basaran GA; Darendeliler E; Ozger H; Onat H; Bavbek S
Tohoku J Exp Med; 2007 Nov; 213(3):221-9. PubMed ID: 17984619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
